About
NeuroDegenerative
- Arimoclomol
Oncology
- Aldoxorubicin
- LADR™
Investors
News & Events
- Press Releases
- Virtual Event
Contact

About
NeuroDegenerative
- Arimoclomol
Oncology
- Aldoxorubicin
- LADR™
Investors
News & Events
- Press Releases
- Virtual Event
Contact

Stock Information

Home Investor Relations Stock Information

Stocks

Previous Close	52 Week Range

Stocks

Volume	Marketcap

Need Information?

310-826-5648 info@ladrxcorp.com

Investor Relations

Investor Relations
Stock Information
Investor FAQs
Analyst Coverage
Annual Reports
SEC Filings
Corporate Governance
Presentations
Email Alerts
Information Request
Online Investor Kit

About
NeuroDegenerative
Oncology
Investors
News & Events
Contact

© 2022 LadRx Corporation